461 related articles for article (PubMed ID: 30470967)
1. Direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: focus on real life studies.
Masotti L; Grifoni E; Dei A; Vannucchi V; Moroni F; Panigada G; Spolveri S; Landini G
J Thromb Thrombolysis; 2019 Feb; 47(2):292-300. PubMed ID: 30470967
[TBL] [Abstract][Full Text] [Related]
2. Confidence in the Use of Direct Oral Anticoagulants in the Acute Phase of Nonvalvular Atrial Fibrillation-Related Ischemic Stroke Over the Years: A Real-World Single-Center Study.
Moroni F; Masotti L; Vannucchi V; Chiarelli R; Seravalle C; Pesci A; Pallini F; Puliti S; Cimolato B; Fattorini L; Scerra C; Ristori F; Imbalzano ML; Spolveri S; Landini G; Grifoni E; Paciaroni M
J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):76-82. PubMed ID: 28918086
[TBL] [Abstract][Full Text] [Related]
3. Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation.
Giustozzi M; Acciarresi M; Agnelli G; Caso V; Bandini F; Tsivgoulis G; Yaghi S; Furie KL; Tadi P; Becattini C; Zedde M; Abdul-Rahim AH; Lees KR; Alberti A; Venti M; D'Amore C; Giulia Mosconi M; Anna Cimini L; Bovi P; Carletti M; Rigatelli A; Cappellari M; Putaala J; Tomppo L; Tatlisumak T; Marcheselli S; Pezzini A; Poli L; Padovani A; Vannucchi V; Sohn SI; Lorenzini G; Tassi R; Guideri F; Acampa M; Martini G; Ntaios G; Athanasakis G; Makaritsis K; Karagkiozi E; Vadikolias K; Liantinioti C; Theodorou A; Halvatsiotis P; Mumoli N; Galati F; Sacco S; Tiseo C; Corea F; Ageno W; Bellesini M; Silvestrelli G; Ciccone A; Lanari A; Scoditti U; Denti L; Mancuso M; Ferrari E; Ulivi L; Orlandi G; Giannini N; Tassinari T; Luisa De Lodovici M; Rueckert C; Baldi A; Toni D; Letteri F; Giuntini M; Maria Lotti E; Flomin Y; Pieroni A; Kargiotis O; Karapanayiotides T; Monaco S; Maimone Baronello M; Csiba L; Szabó L; Chiti A; Giorli E; Del Sette M; Imberti D; Zabzuni D; Doronin B; Volodina V; Michel P; Vanacker P; Barlinn K; Barlinn J; Deleu D; Gourbali V; Paciaroni M; Masotti L
Stroke; 2020 Aug; 51(8):2347-2354. PubMed ID: 32646335
[TBL] [Abstract][Full Text] [Related]
4. Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study.
Yasaka M; Minematsu K; Toyoda K; Yamagami H; Yoshimura S; Nagao T; Mori E; Hirano T; Hamasaki T; Yamaguchi T
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1342-8. PubMed ID: 26987488
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and Safety of Direct Oral Anticoagulants in the Secondary Stroke Prevention of Elderly Patients: Ljubljana Registry of Secondary Stroke Prevention.
Frol S; Sernec LP; Hudnik LK; Šabovič M; Oblak JP
Clin Drug Investig; 2020 Nov; 40(11):1053-1061. PubMed ID: 32886321
[TBL] [Abstract][Full Text] [Related]
6. Reduced Doses of Direct Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.
Deguchi I; Takao M
J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):354-359. PubMed ID: 30401611
[TBL] [Abstract][Full Text] [Related]
7. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
8. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
[TBL] [Abstract][Full Text] [Related]
9. Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial.
Åsberg S; Hijazi Z; Norrving B; Terént A; Öhagen P; Oldgren J
Trials; 2017 Dec; 18(1):581. PubMed ID: 29197413
[TBL] [Abstract][Full Text] [Related]
10. Associations between Pre-Admission Risk Scores and Two-Year Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients with Non-Valvular Atrial Fibrillation.
Tokunaga K; Yamagami H; Koga M; Todo K; Kimura K; Itabashi R; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Shibuya S; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Kario K; Yagita Y; Kitazono T; Kinoshita N; Takasugi J; Okata T; Yoshimura S; Sato S; Arihiro S; Toyoda K;
Cerebrovasc Dis; 2018; 45(3-4):170-179. PubMed ID: 29597211
[TBL] [Abstract][Full Text] [Related]
11. Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation - SAMURAI-NVAF Study.
Yoshimura S; Koga M; Sato S; Todo K; Yamagami H; Kumamoto M; Itabashi R; Terasaki T; Kimura K; Yagita Y; Shiokawa Y; Kamiyama K; Okuda S; Okada Y; Takizawa S; Hasegawa Y; Kameda T; Shibuya S; Nagakane Y; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Fujita K; Kamimura T; Ando D; Ide T; Yoshimoto T; Shiozawa M; Matsubara S; Yamaguchi Y; Kinoshita N; Matsuki T; Takasugi J; Tokunaga K; Higashida K; Homma K; Kario K; Arihiro S; Toyoda K;
Circ J; 2018 Jun; 82(7):1935-1942. PubMed ID: 29863095
[TBL] [Abstract][Full Text] [Related]
12. Ninety-day prognosis of patients receiving direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: The real life evidence.
Masotti L; Grifoni E; Dei A; Vannucchi V; Moroni F; Spolveri S; Panigada G; Landini G
Thromb Res; 2018 Dec; 172():165-168. PubMed ID: 30419471
[No Abstract] [Full Text] [Related]
13. Early Initiation of Direct Oral Anticoagulants After Onset of Stroke and Short- and Long-Term Outcomes of Patients With Nonvalvular Atrial Fibrillation.
Mizoguchi T; Tanaka K; Toyoda K; Yoshimura S; Itabashi R; Takagi M; Todo K; Shiozawa M; Yagita Y; Yoshimoto T; Terasaki T; Yamagami H; Takizawa S; Inoue M; Kamiyama K; Ihara M; Okada Y; Kitazono T; Koga M;
Stroke; 2020 Mar; 51(3):883-891. PubMed ID: 31964290
[TBL] [Abstract][Full Text] [Related]
14. Direct Oral Anticoagulants in Patients Undergoing Urgent Reperfusion for Nonvalvular Atrial Fibrillation-Related Ischemic Stroke: A Brief Report on Literature Evidence.
Masotti L; Grifoni E; Dei A; Vannucchi V; Moroni F; Panigada G; Nicotra C; Spolveri S; Landini G
Neurol Res Int; 2019; 2019():9657073. PubMed ID: 30923637
[TBL] [Abstract][Full Text] [Related]
15. Patterns and outcomes of switching direct oral anticoagulants in non-valvular atrial fibrillation: A real-world experience from Spain.
Rodilla E; Orts-Martínez MI; Sanz-Caballer MA; Gimeno-Brosel MT; Arilla-Morel MJ; Navarro-Gonzalo I; Castillo-Valero I; Salvador-Mercader I; Carral-Tatay A
Rev Clin Esp (Barc); 2023; 223(6):340-349. PubMed ID: 37105383
[TBL] [Abstract][Full Text] [Related]
16. Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis.
Chan YH; Lee HF; Chao TF; Wu CT; Chang SH; Yeh YH; See LC; Kuo CT; Chu PH; Wang CL; Lip GYH
Cardiovasc Drugs Ther; 2019 Dec; 33(6):701-710. PubMed ID: 31745687
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
[TBL] [Abstract][Full Text] [Related]
18. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
[TBL] [Abstract][Full Text] [Related]
19. Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack.
Minematsu K; Ikeda T; Ogawa S; Kitazono T; Nakagawara J; Miyamoto S; Murakawa Y; Takeichi M; Kidani Y; Okayama Y; Sunaya T; Sato S; Yamanaka S
Cerebrovasc Dis; 2019; 48(1-2):53-60. PubMed ID: 31578012
[TBL] [Abstract][Full Text] [Related]
20. Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study.
Paciaroni M; Agnelli G; Falocci N; Caso V; Becattini C; Marcheselli S; Rueckert C; Pezzini A; Poli L; Padovani A; Csiba L; Szabó L; Sohn SI; Tassinari T; Abdul-Rahim AH; Michel P; Cordier M; Vanacker P; Remillard S; Alberti A; Venti M; Scoditti U; Denti L; Orlandi G; Chiti A; Gialdini G; Bovi P; Carletti M; Rigatelli A; Putaala J; Tatlisumak T; Masotti L; Lorenzini G; Tassi R; Guideri F; Martini G; Tsivgoulis G; Vadikolias K; Liantinioti C; Corea F; Del Sette M; Ageno W; De Lodovici ML; Bono G; Baldi A; D'Anna S; Sacco S; Carolei A; Tiseo C; Acciarresi M; D'Amore C; Imberti D; Zabzuni D; Doronin B; Volodina V; Consoli D; Galati F; Pieroni A; Toni D; Monaco S; Baronello MM; Barlinn K; Pallesen LP; Kepplinger J; Bodechtel U; Gerber J; Deleu D; Melikyan G; Ibrahim F; Akhtar N; Mosconi MG; Bubba V; Silvestri I; Lees KR
Stroke; 2015 Aug; 46(8):2175-82. PubMed ID: 26130094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
